1-5 FDA removal of RU-486


that the Catholic Medical Association calls upon the Food and
Drug Administration to respond to citizens petitions calling for
Removal of RU-486 from the market in an urgent action.
(2005) (renewed 2015)

1-6 Support federal law that prohibits physician participation in abortion


that the Catholic Medical Association supports the current
Federal law which protects the physician from being coerced
into referring for abortion. (2005) (renewed 2015)

1-9 Opposition to abortion and the distribution and sale of baby body parts


that the CMA continue to advocate for protection of pre-born
babies, condemn any abortion, and to affirm with clarity the
value of human life, and Be it resolved, that the CMA oppose
any unethical and immoral procurement, distribution, and sale
of babies or baby body parts including embryos, fetuses and
baby body parts, babies who died from induced abortions or
stillborns or infants (both alive or dead) and human cell lines
(as per Dignitas Personae, section 35), and Be it resolved, that
the CMA support that aborted babies be buried or cremated to
show due respect to God’s littlest ones and to help halt the sale
of aborted baby body parts. (2015)

1-10 Resolution on expansion of medical abortion


that the FDA require a central manufacturer for all those
having a medical abortion, with mandatory reporting from
every state and territory of complications and moralities from
medical abortions; that the drug be administered only by a
physician with surgical privileges at a hospital within 30
minutes of the facility where the drug is dispensed; that the
dispensing physician be responsible for follow-up and handling
of complications; and that the patient be informed that the
process could be stopped without harm to her or the baby.

1-11 Resolution on induced abortion as a risk for breast cancer


that the Catholic Medical Association supports the education of physicians
of the increased breast cancer risk with induced abortion; further, supports
that all healthcare professionals fully inform their patients of these risks and
appropriate breast cancer screening (2017)